Clinical Trials Logo

Clinical Trial Summary

This is a single-arm hybrid implementation trial of men with metastatic castrate-resistant prostate cancer (mCRPC) involving a clinician-prompted, patient-administered mobile app tailored for consultation audio recordings.

Clinical Trial Description

PRIMARY OBJECTIVE: 1. To evaluate change in participant informed decision-making after provision of a consultation audio recording application. SECONDARY OBJECTIVES: 1. Reach. To evaluate the percentage of invited participants who enroll. Reasons for not enrolling will be assessed. 2. Adoption. To evaluate the percentage of providers who agree to be recorded. 3. Adoption. To evaluate the percentage of participants who create an audio recording. 4. Adoption. To evaluate the percentage of participants who listen to the audio recording or read its automatically generated transcript. 5. Implementation. To evaluate the percentage of participants who report receiving instructions on how to record. 6. To evaluate participant-reported shared decision-making effort. 7. To evaluate whether participant-reported anxiety changes after provision of a consultation audio recording app. 8. To evaluate barriers, facilitators, and experiences of recording app use, particularly in the context of treatment decision-making by conducting participant interviews, provider surveys, and interviews with providers. 9. Treatment received. EXPLORATORY OBJECTIVES: 1. To evaluate whether provision of a consultation audio recording app improves participant-reported knowledge retention of docetaxel. 2. To evaluate accuracy of app auto-generated transcription. 3. To evaluate degree of provider decision support and communication skills. Participants are set up with the application prior to their first physician visit and then followed-up 7 days, 28 days and 60 days after their physician encounter. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05127850
Study type Interventional
Source University of California, San Francisco
Contact UCSF Genitourinary Medical Oncology
Phone 877-827-3222
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date January 15, 2022
Completion date March 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04081636 - Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications N/A
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Recruiting NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Active, not recruiting NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Active, not recruiting NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A
Active, not recruiting NCT00499421 - Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
Not yet recruiting NCT04887935 - Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer Phase 1
Recruiting NCT04838613 - Study of Diagnostic Performance of [18F]CTT1057 in BCR Phase 3
Recruiting NCT05019846 - SRT Versus SRT+ADT in Prostate Cancer Phase 3
Not yet recruiting NCT05035732 - RRPC Axumin PETMRI N/A
Not yet recruiting NCT05033301 - Evaluating the Effectiveness of the Nurse Ned Clinic N/A
Recruiting NCT03668652 - Focal Prostate Ablation Versus Radical Prostatectomy N/A